The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•22 April 2026•

1 min read

Johnson & Johnson Secures European CE Mark for Advanced ETHICON 4000 Stapler

Icy Unilever headquarters with gears and clocks on a world map background. Signs read 'HIRING PAUSED' and 'FROZEN'. People work at computers below.

Key Facts

1Johnson & Johnson received the European CE Mark approval for its ETHICON 4000 Stapler for use in open and laparoscopic surgeries.

2The company plans to integrate this technology with the OTTAVA Robotic Surgical System in the future.

Johnson & Johnson's MedTech division has successfully secured the European CE Mark for its ETHICON 4000 Stapler, designed for both open and laparoscopic surgical procedures. This advanced device incorporates proprietary 3D Stapling and Gripping Surface technologies to improve surgical precision and tissue management. Looking ahead, the company intends to integrate this stapling technology with its OTTAVA Robotic Surgical System to bolster its robotic-assisted surgery offerings. The approval allows Johnson & Johnson to market these advanced surgical solutions across the European Union, aiming to reduce clinical complications. This regulatory milestone strengthens the market position of the Ethicon brand within the competitive medical device sector. The move underscores the company's strategic focus on digital surgery innovation and high-growth healthcare segments.